New Zealand markets open in 2 hours 13 minutes

Medifast, Inc. (MED)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
33.35+0.75 (+2.29%)
As of 03:46PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 355.20M
Enterprise value 227.17M
Trailing P/E 3.58
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.33
Price/book (mrq)1.76
Enterprise value/revenue 0.21
Enterprise value/EBITDA 1.63

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-64.09%
S&P500 52-week change 323.06%
52-week high 3109.52
52-week low 330.95
50-day moving average 338.40
200-day moving average 365.89

Share statistics

Avg vol (3-month) 3381.23k
Avg vol (10-day) 3355.17k
Shares outstanding 510.9M
Implied shares outstanding 610.9M
Float 89.8M
% held by insiders 12.70%
% held by institutions 197.76%
Shares short (28 Mar 2024) 42.66M
Short ratio (28 Mar 2024) 45.83
Short % of float (28 Mar 2024) 437.11%
Short % of shares outstanding (28 Mar 2024) 424.43%
Shares short (prior month 29 Feb 2024) 41.94M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 420.25%
Trailing annual dividend rate 34.95
Trailing annual dividend yield 315.18%
5-year average dividend yield 44.51
Payout ratio 454.40%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 9.27%
Operating margin (ttm)4.54%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)55.77%

Income statement

Revenue (ttm)1.07B
Revenue per share (ttm)98.50
Quarterly revenue growth (yoy)-43.40%
Gross profit (ttm)N/A
EBITDA 139.51M
Net income avi to common (ttm)99.42M
Diluted EPS (ttm)9.10
Quarterly earnings growth (yoy)-77.20%

Balance sheet

Total cash (mrq)150.04M
Total cash per share (mrq)13.92
Total debt (mrq)22.01M
Total debt/equity (mrq)10.93%
Current ratio (mrq)2.43
Book value per share (mrq)18.69

Cash flow statement

Operating cash flow (ttm)147.66M
Levered free cash flow (ttm)106.22M